Pellant A, Kerekes Z
Cesk Otolaryngol. 1989 Mar;38(2):116-20.
Only comprehensive treatment comprising active screening of risk groups, treatment proper, primary and secondary prevention and permanent collaboration of the clinician and pathologist can improve significantly the prognosis (morbidity and mortality) of patients with precanceroses of the larynx. Subsequent dispensary care then improves by cca 10% the five-year survival of patients with confirmed malignancies, as compared with the therapeutic results of all treated carcinomas of the larynx during the corresponding period.
只有包括对危险人群进行积极筛查、适当治疗、一级和二级预防以及临床医生与病理学家的长期合作在内的综合治疗,才能显著改善喉癌前病变患者的预后(发病率和死亡率)。与同期所有接受治疗的喉癌的治疗结果相比,随后的门诊治疗可使确诊恶性肿瘤患者的五年生存率提高约10%。